|Bid||30.55 x 200|
|Ask||30.75 x 100|
|Day's Range||30.50 - 31.23|
|52 Week Range||29.39 - 49.09|
|PE Ratio (TTM)||30.69|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|
New Hampshire will be getting $1 million from EpiPen maker Mylan as part of a national settlement. The company this week finalized a $465 million federal agreement settling allegations it overbilled Medicaid ...
Mylan N.V. (MYL) signed an agreement with the U.S. Department of Justice (DOJ) and two other relators to finalize the Medicaid drug rebate settlement worth $465 million, announced in Oct 2017.
Mylan has finalized a $465M settlement with the U.S. DOJ and other government agencies over the classification of its EpiPen auto injectors in the Medicaid Drug Rebate Program